• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
  • Contact

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • Sponsored Placement
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

Employees View Alcohol, Drug Use As Benefit Of Work-From-Home During Pandemic - May Bring Drug Habits Back To Workplace, Sierra Tucson Survey Shows

A FIFTH OF EMPLOYEES ADMIT TO BEING HIGH ON VIRTUAL CALLS; 73% OF THOSE WHO USED DRUGS SAY THEY'LL MISS USING DRUGS IF THEY RETURN TO WORKPLACE


News provided by

Sierra Tucson

Nov 10, 2021, 08:00 ET

Share this article

Share this article


TUCSON, Ariz., Nov. 10, 2021 /PRNewswire/ -- A staggering one in five (21%) U.S. employees admit they've used alcohol, marijuana or other recreational drugs while employed remotely this year – a similar percentage admitted using alcohol during the workday. Of those who used, three out of four (73%) state that if their employer insists that they return to the office, they'll miss the opportunity to use marijuana, alcohol and other recreational drugs during their workday.

And what about drugs and virtual meetings on platforms such as Zoom or MS Teams? Twenty-two percent of employees surveyed said they had participated in a virtual work call while under the influence of marijuana, alcohol or other recreational drugs!

Those are among the stunning findings of the new "Self-Medication Nation: The Numbing of America" survey, commissioned by Arizona-based mental health treatment center Sierra Tucson. Among the other conclusions of Sierra Tucson's "Self-Medication Nation" Ipsos survey:

  • A fifth of employees surveyed (21%) by Sierra Tucson said they witnessed a colleague under the influence of marijuana, alcohol or other recreational drugs during a virtual meeting during the workday.
  • When asked why they preferred to work from home versus returning to work at their office, 14% said it's because they can drink alcohol to relax during the workday and 11% said because they can use marijuana or other drugs to relax during their workday.
  • More than a quarter (28%) of all employees surveyed said that an added benefit of working from home was the opportunity to use alcohol and other recreational drugs during the workday while at home.

"Our survey makes clear that innumerable American workers have been self-medicating with alcohol, marijuana and other drugs to cope with the stress, anxiety, loneliness and depression caused by the pandemic," says Dr. Jasleen Chhatwal, chief medical officer of Sierra Tucson. 

"Incredibly, drug use is seen by many employees as an added benefit of working remotely," adds Dr. Chhatwal. "And that makes us in the addiction treatment field wonder – how many of these employees will continue to use these substances as they return to the workplace or to hybrid schedules?  In fact, we're already seeing patients here at Sierra Tucson who were referred to us for treatment by employers – because they were affected by substances while at work, as well as at home. Bottom line: what starts during work-from-home may well continue as employees return to their workplaces. Employers that truly care about the health of their employees must be ready."

Employees Turning to Drugs, Rather Than Therapy
More than half (58%) of people surveyed said they'd used alcohol and one in five (21%) used marijuana since the pandemic started. But strikingly, of those who used marijuana, 41% said they used marijuana to cope with stress, 38% to cope with anxiety, 20% to deal with loneliness, 31% with depression.

"What concerns our addiction clinicians is that barely 13% of those surveyed spoke with a therapist as a result of anxiety, depression or other mental health issues," says Dr. Chhatwal. "Instead of coping with pandemic-sparked mental health issues through therapy, America's employees are turning to drugs and alcohol. And without treatment and counseling, those people are bringing their use of recreational drugs while working at home, back to the office with them."

Pandemic Inspires Heavy Drinking
Lastly, 38% of survey respondents who consumed alcohol said that during the pandemic their consumption of alcohol increased – but it's the size of some of the increases that surprised Sierra Tucson. "Our survey found that of those 38% who increased their alcohol consumption during the pandemic – 85% increased by 1 to 3 drinks a day," says Dr. Chhatwal. "That means some Americans are potentially adding an additional 21 drinks a week to what they were already consuming. It's vital that families, friends, co-workers and business managers are aware – and encourage their loved ones and friends to seek professional help as the fourth wave of the pandemic continues to impact the mental wellbeing of millions of Americans."

For more information about the "Self-Medication Nation" survey results, visit:  sierratucson.com/selfmedicationnation and watch Sierra Tucson's chief medical officer Dr. Jasleen Chhatwal here: https://youtu.be/lRCUuWja44g 

Media Interviews Available: Interviews about the "Self-Medication Nation" survey are available with chief medical officer Dr. Jasleen Chhatwal and other clinicians. Please contact Elyse at 651-470-0063 or Paul, 612-366-5287.

About the Sierra Tucson "Self-Medication Nation" Survey: This project was fielded from July 29 through August 13, 2021 amongst a US nationally representative sample of 18 to 64 year olds. Ipsos utilized an online quantitative survey in the implementation of this research, recruiting 1,000 qualified respondents from a trusted network of online panels. As a standard best practice with online studies at Ipsos, the sample for this study was blended from multiple online panels.  Respondents were invited to participate in the survey via an email sent from each sample partner.

About Sierra Tucson: Established in 1983 on a 160-acre campus, Sierra Tucson is an internationally renowned leader in the treatment of addictions, mental/behavioral disorders, and chronic pain. Dually accredited by The Joint Commission, Sierra Tucson's integrated system of neuropsychiatric treatment and comprehensive medical and clinical care heals body, mind, and spirit. Evidence-based practices combine with integrative and experiential therapies to provide a full range of traditional and innovative treatment modalities. For more information, visit: https://www.sierratucson.com

SOURCE Sierra Tucson

Modal title

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2023 Cision US Inc.